Scientists at Cincinnati Children's have taken a key early step in understanding why some people born with the rare disease Adams-Oliver syndrome (AOS) experience potentially fatal disruptions in ...
Xeltis’ vascular access graft, aXess, recently demonstrated strong efficacy in an EU pivotal trial in patients with end-stage renal disease.
Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces that it has secured nearly EUR50m of new financing, ...
Xeltis announced today that it secured €47.5 million ($55.1 million) in financing to support its vascular access device.
New research on fern vascular systems reveals how developmental constraints don't just limit evolution—they generate new ...
Up to €37.5m investment from the EIB, consisting of €10m upfront with optionality to further increase by an additional €27.5m€10m investment from existing ...
Heart is like the engine that drives the body smoothly. From pumping blood rich in oxygen and nutrients to every organ and ...
Thepatent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to patients ...
Should you run a humidifier near your Christmas tree? Experts share their thoughts and alternative tips to extend your tree’s ...
Medical Beauty Lasers Market projected to reach USD 7,955.0 Mn by 2035, growing at a 8.3% CAGR — driven by rising demand for ...
As per the National Kidney Foundation, millions of people are suffering from kidney diseases and mostly because of irregular ...